drugset / Trial / NCT04352153

Role of Uralyt-U in Patients With Hyperuricemia

NCT04352153

Unknown 102 enrolled Ai Peng
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to provide a more direct and objective basis for the widespread use of potassium sodium hydrogen citrate granules in the treatment of uric acid stones.

Timeline

Start
2020-04-01
Primary completion
2020-09-30
Completion
2020-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject POTASSIUM SODIUM HYDROGEN CITRATE ANHYDROUS Small molecule 2.5 g Oral
Background Febuxostat Small molecule 20 mg Oral

Indications